CNS Flashcards
1st line tx of focal seizures
lamotrigine/levetiracetam
2nd line tx of focal seizures
carbamazepine, oxcarbazepine, zonisamide
different types of generalised seizures
-tonic-clonic
-absence
-absence + other
-myoclonic
-atonic
-tonic
-for child-bearing age = 2nd line tx
tx of tonic-clonic seziures
1)sodium valproate
2)lamotrigine, levetiracetam
tx of absense seizures
1)ethosuximide
2)sodium valporate
tx of absence + other type of seizures
1)sodium valproate
2) lamotrigine/ levetiracetam
myoclinic seziures tx
1)sodium valproate
2) levetriacetam
atonic seziures tx
1)sodium valproate
2)lamotrigine
tonic seizures tx
1)sodium valproate
2)lamotrigine
what is status epilepticus
-seizures that last longer than 5 mins
-need to provide resuscitation and immediate emergency tx
1)pt = individualised emergency manage plan
2)pt = x “”
status epilepticus tx
-Standard tx
1) longer than 5 mins
->IV lorazepam (resuscitation if available)
->buccal midazolam/rectal diazepam (community)
–>give second dose if seizure x stop within 5-10mins of 1st dose
2)if seizure x respond after 2x benzodiazepine doses
-> levetiracetam, phenytoin, sodium valproate
3) if seizure fails to respond try another 2nd line if still x respond
->phenobarbital/general anaesthesia
category 1 of anti-epileptic drugs
-specific brands only
-carbamazepine, phenobarbital, phenytoin, primidone
category 2 of anti-epileptic drugs
- maintain specific brands based on clinical judgement + pt factors
-clobazam, clonazepam, lamotrigine, oxcarbazepine, perampanes, rufinamide, topiramate, valproate, zonisamide
category 3 of anti-epileptic drugs
-unnecessary to ensure - specific brands
- brivaracetam, ethosuximide, gabapentin, laxosamide, levetiracrtam, pregabalin, tigabine, vigabatrin
anti-epileptic drug interactions
(carbamazepine, phenytoin, sodium valproate)
-hepatotoxicity - amiodarone, itraconazole, macrolides, alcohol
-CYP enzymes - inducers (phenytoin, phenobarbital + carbamazepine) inhibitors (sodium valproate)
-drugs lower seizure threshold - tramadol, theophylline, quinolones, —>carbamazepine = hyponatraemic drugs (SSRI + diuretics)
->phenytoin = anti-folate(methotrex + trimethoprim)
carbamazepine, phenytoin, sodium valproate s/e
-carbamazepine, phenytoin, sodium valproate
->suicide, depression, hepatotoxicity, hypersensitivity, blood dyscrasia, vit D deficiency
-carbamazepine; hyponatraemia, odema
-phenytoin; coarsening appearance, facial hair
-sodium valproate; pancreatitis, teratogenic
anti-epileptic drug s/e
-hypersensitivity - carbamazepine, phenobarbital, phenytoin, primidone, lamotrigine
-skin rash - lamotrigine (steven-johnson syndrome)
-blood dyscrasia - carbamazepine, valproate, ethosuximide, topiramate, phenytoin, lamotrigine, zonisamide
-eye disorder - vigabatrin (reduce visual field) topiramate (secondary glaucoma)
-encephalopathy - vigabatrin
-respiratory depression - gabapentin + pregabalin
carbamazepine range + signs of toxicity
-therapeutic range- 4-12mg/l
-Hyponatraemia
-ataxia (poor muscle control)
-nystagmus (involuntary movement of eyes)
-drowsiness
-blurred vision
-arrythmias
-GI disturbances
phenytoin range + signs of toxicity
-therapeutic range - 10-20mg/l
-slurred speech
-nystagmus (involuntary mov of eyes)
-ataxia (poor muscle control)
-confusion
-hyperglycaemia
-double vision
epilepsy + driving
-stop driving + inform DVLA (fit)
-1st unprovoked/single isolated = 6MT
-established epilepsy = 1yr (or pattern of seizures established for 1yr with no impact on consciousness)
-medication change/withdrawal - x drive 6MT after last dose, seizure = occur license removed for 1yr, reinstated for after 6MT if tx resumed + no seizure occur
epilepsy + pregnancy
-risk of harm to mother + fetus from convulsive seizures outweighs risk of continued therapy
-folic acid given to reduce risk of neural tube defects in 1st trimester
-vit K inj adminstered - birth reduces neonatal haemorrhage
-most risk - sodium val -PPI
- topiramate - celft palate
what is bipolar disorder
extreme fluctuation between maniac phases (overactive + excitability) + depressive phases (reclusive + lethargic)
tx acute of bipolar disorder
-benzodiazepines
-antipyschotics (quetiapine, olanzapine/risperdone)
-> add lithium or sodium valproate
tx prophylaxis of bipolar disorder
-carbamazepine, sodium valproate or lithium
lithium range
-therapeutic range - 0.4-1mmol/l (acute episodes - 0.8-1)
-measure levels 12hr after each dose - weekly till stable then 3MT X 1YR * 6MT
lithium toxicity
-CUT-DVB
Renal impairment - incontinence
-extrapyramidase s/e - tremor
-visual disturbance - blurred vision
-nervous system disorder - confusion + restlessness
-diarrhoea + vomiting
lithium s/e
-QT2-BNR
thyroid disorder
-nephrotoxicity
-rhabdomyolysis
-QT prolongation
-benign intercranial hypertension
-1st trimester = teratogenic
lithium interactions
-hyponatraemia = high risk of toxicity - diuretics
-salt imbalance
-serotonin syndrome
-extrapyramidal s/e
-QT prolongation
-renally cleared drugs (high risk of toxicity
-dec seizure threshold
-hypokalmaeia
dementia?
alleviated by high amount of acetylcholine
tx of dementia mild to moderate
-acetylcholinesterase inhibitors
-donepezil = neuroleptic malignant syndrome
-rivastigmine - GI s/e - less in transdermal formulations
-galantamine -steven-johnsons syndrome
tx of dementia moderate to severe
- memantine
-aggravation tx with benzodiazepines or antipsychotics
s/e of dementia tx
-high acetylcholine = parasympathetic s/e
-stop tx + tx dehydration before reinitiating/amending dose
-diarrhoea
-urinary incontience
-muscle weakness
-bradycardia
-bronchospasm
-emetis
-lacrimation
-salivation
parkinsons?
alleviated levels of dopamine
pt = parkinsons whose motor symptoms reduce QoL tx
levodopa + carbidopa/berserazide
pt = parkinsons whose motor symptoms x affect QoL TX
- levodopa
-non-ergot derived dopamine receptor
-monoamine-oxidase B inhibitors
what is added to levodopa in order to prevent breakdown of levodopa before it crosses into the brain
-carbidopa/benserazide is added
-impulsive disorders; pathological gambling, binge eating, hypersexuality
-sudden onset of sleep (tx modafinil) red urine
non-ergot derived dopamine-receptor -
pramipexole, ropinirole + rotigotine
-impulse disorders (higher than levodopa)
-sudden onset of sleep
-hypotension
-rasagiline or selegiline interactions
monoamine-oxidase B inhibitors
-causes hypertensivie crisis if given with phenyleprine
-interacts with tyramine rich foods
->mature cheese, salami, marmite, yeast, tofu
when is non-ergot dopamine receptor agonists, monoamine oxidase B inhibitors or COMT inhibitors added to levodopa
it is added to levodopa in pt who develops dyskinesia or motor fluctuations despite optimal levodopa therapy
entacapone and tolcapone
-COMT inhibitors
-entacapone - red-brown urine
- tolcapone - hepatotoxic
- inc sympathetic s/e in CVD events
when is ergot dervied dopamine receptor agonist added to levodopa
- if symptoms x adequately controlled with non-ergot “”
ergot dervied receptor agonists -
bromocriptine, cabergoline
- pulmonary reactions; report SoB, chest pain, cough
-pericardial reactions; chest pain
withdrawal of medications
-if person = off-periods due to deterioation use MR preparations
-tx natural akinesia with levodopa or oral dopamine receptor agonists as 1st line + rotigotine - 2nd line
-tx hypertension = midodrine
psychosis + schizophrenia +ve symptoms
delusions, hallucinations, disorganisations
psychosis + schizophrenia -ve symptoms
social withdrawal, neglect, poor hygiene
antipsychotics 1st gen
phenothiazines
thioxanthenes
butyprohenones
antipsychotics 2nd gen
olanzapine
clozapine
risperidone
quetiapine
aripiprazole
ziprasidone
paliperidone
asenapine
lurasidone
iloperidone
antipsychotics how many groups of phenothiazines
group 1
group 2
group 3
1st gen phenzothiazines group 1
-chlorpromazine, levomepromazine, promazine
-most sedation, moderate antimuscarinic + EPSEs
1st gen phenzothiazines group 2
-pericyazine
-moderate sedation least EPSEs